The role of patient advocacy in shaping early clinical development

Patient advocacy organizations play an increasingly important role in early clinical development by bringing forward patient priorities, unmet needs, and real-world insights. This session explores how structured collaboration with advocacy groups can strengthen trial design, enhance translational fidelity, and support more meaningful early clinical outcomes.
Key takeaways

• Incorporate advocacy insights to align early clinical studies with patient needs
• Inform endpoint selection and biomarker strategies with real-world perspectives
• Enhance trial accessibility and engagement through an advocacy partnership
• Identify translational considerations influenced by patient heterogeneity and disease burden
• Build communication frameworks that support ongoing feedback during early development